Panel: A Look at Biopharma M&A and Shifting Deal Dynamics

In A Look at Biopharma M&A and Shifting Deal Dynamics, industry leaders from Merck, Avenzo Theraputics and Astellas Pharma will examine the intricacies of biopharma transactions and a future of regulatory challenges and changed market forces.